Equity Details
Price & Market Data
Price: $18.31
Daily Change: +$0.21 / 1.15%
Daily Range: $17.70 - $18.55
Market Cap: $2,120,681,472
Daily Volume: 1,228,865
Performance Metrics
1 Week: 15.30%
1 Month: 70.80%
3 Months: 74.88%
6 Months: 67.67%
1 Year: -1.40%
YTD: 41.61%
About NovoCure Limited (NVCR)
Explore NovoCure Limited (NVCR)'s performance at a glance. Current price: 18.31, daily change: +$0.21 / 1.15%. Market cap: 2,120,681,472. Focus on its YTD and 3-month performance.
Company Details
Employees: 1605
Sector: Health technology
Industry: Medical specialties
Country: United Kingdom
Details
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.